Theodore J Catino

Title: The Innovations of Theodore J Catino

Introduction

Theodore J Catino is a notable inventor based in Attleboro, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of gene expression and cancer research. With a total of four patents to his name, Catino's work has implications for diagnostic and therapeutic advancements.

Latest Patents

Catino's latest patents include a method for detecting a differentially expressed sequence. This invention relates to novel human genes, proteins expressed by these genes, and variants of the proteins. It also encompasses diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue. Another significant patent is titled "Human genes and gene expression products: II," which shares similar themes of novel human genes and their applications in diagnostics and therapeutics.

Career Highlights

Throughout his career, Catino has worked with prominent organizations such as Bayer Corporation and the Mayo Foundation for Medical Education and Research. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Catino's notable coworkers include Jon H Astle and Christopher C Burgess. Their collaborative efforts have furthered the understanding of gene expression and its implications in cancer research.

Conclusion

Theodore J Catino's innovative work in biotechnology and his contributions to the understanding of human genes have positioned him as a significant figure in the field. His patents reflect a commitment to advancing medical science and improving diagnostic and therapeutic options for cancer treatment.